✦ LIBER ✦

A study of paclitaxel, carboplatin, and bortezomib in the treatment of metastatic malignant melanoma : A phase 2 Consortium study

✍ Scribed by Gary A. Croghan; Vera J. Suman; William J. Maples; Mark Albertini; Gerald Linette; Lawrence Flaherty; John Eckardt; Cynthia Ma; Svetomir N. Markovic; Charles Erlichman

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 154 KB
Volume: 116
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25191

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of bortezomib in the tr

A phase II study of bortezomib in the treatment of metastatic malignant melanoma

✍ Svetomir N. Markovic; Susan M. Geyer; Fitzroy Dawkins; William Sharfman; Mark Al 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

A multicenter Phase II study of bortezom

A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomas

✍ Robert G. Maki; Andrew S. Kraft; Kelly Scheu; Jennifer Yamada; Scott Wadler; Cri 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

Results of a multicenter, randomized, do

Results of a multicenter, randomized, double-blind, dose-evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanoma

✍ John Glaspy; Michael B. Atkins; Jon M. Richards; Sanjiv S. Agarwala; Steven O'Da 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 1 views

Results of a multicenter, randomized, do

Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma

✍ Tim Eisen; Uwe Trefzer; Anne Hamilton; Peter Hersey; Michael Millward; Robert D. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB 👁 1 views

A phase I study of a weekly schedule of

A phase I study of a weekly schedule of paclitaxel and carboplatin in patients with advanced carcinoma

✍ Wallace Akerley; Ritesh Rathore; Neil Ready; Louis Leone; William Sikov; Howard 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 1 views

## Background: We conducted a phase i study of weekly paclitaxel (p) and carboplatin (c) in patients with advanced malignancies to determine the maximum tolerated dose (mtd) of this combination. ## Methods: Dose levels were escalated independently for patients with and without previous chemothera

Bevacizumab and everolimus in the treatm

Bevacizumab and everolimus in the treatment of patients with metastatic melanoma : A phase 2 trial of the Sarah Cannon Oncology Research Consortium

✍ John D. Hainsworth; Jeffrey R. Infante; David R. Spigel; James D. Peyton; Dana S 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB 👁 2 views